
---
title: '重症、死亡保护率100% 首个国产重组新冠病毒蛋白疫苗获批'
categories: 
 - 新媒体
 - 快科技（原驱动之家）
 - 最新新闻
headimg: 'https://img1.mydrivers.com/img/20220302/55b32166-a329-4e4c-806e-69bc086d004b.png'
author: 快科技（原驱动之家）
comments: false
date: Wed, 02 Mar 2022 15:45:09 GMT
thumbnail: 'https://img1.mydrivers.com/img/20220302/55b32166-a329-4e4c-806e-69bc086d004b.png'
---

<div>   
<p class="MsoNormal">财联社消息，国家药监局附条件批准安徽智飞龙科马生物制药有限公司重组新型冠状病毒蛋白疫苗<span lang="EN-US">(CHO</span>细胞<span lang="EN-US">)</span>注册申请。</p>
<p class="MsoNormal"><span style="color:#ff0000;"><strong>该疫苗是首个获批的国产重组新冠病毒蛋白疫苗，适用于预防新型冠状病毒感染所致的疾病<span lang="EN-US">(COVID-19)</span>。</strong></span></p>
<p class="MsoNormal"><span lang="EN-US">2021</span>年<span lang="EN-US">8</span>月份<span style="color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">重庆智飞生物</span>发布了重组新型冠状病毒疫苗（<span lang="EN-US" style="font-family: "Open Sans", sans-serif; color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">CHO</span><span style="color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">细胞）的</span><span lang="EN-US" style="font-family: "Open Sans", sans-serif; color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">III</span><span style="color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">期临床数据。</span><span lang="EN-US" style="font-family: "Open Sans", sans-serif; color: rgb(51, 51, 51); background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"></span></p>
<p class="MsoNormal">重组新型冠状病毒疫苗（<span lang="EN-US">CHO</span>细胞）自<span lang="EN-US">2020</span>年<span lang="EN-US">12</span>月<span lang="EN-US">12</span>日起，陆续在我国湖南省、乌兹别克斯坦、印度尼西亚、巴基斯坦和厄瓜多尔开展国际多中心<span lang="EN-US">Ⅲ</span>期临床试验，计划入组<span lang="EN-US">18</span>周岁以上普通人群共计<span lang="EN-US">29000</span>人，按照<span lang="EN-US">0</span>、<span lang="EN-US">1</span>、<span lang="EN-US">2</span>月的免疫程序共接种<span lang="EN-US">3</span>剂疫苗。</p>
<p class="MsoNormal">截至本次数据分析日，实际共入组<span lang="EN-US">28500</span>人，其中疫苗组<span lang="EN-US">14251</span>例、安慰剂组<span lang="EN-US">14249</span>例。</p>
<p class="MsoNormal">共监测到全程接种后的主要终点病例数<span lang="EN-US">221</span>例，<strong>得出重组新型冠状病毒疫苗对任何严重程度的<span lang="EN-US">COVID-19</span>（新冠肺炎）的保护效力为<span lang="EN-US">81.76%</span>，</strong>达到<span lang="EN-US">WHO</span>（世卫组织）要求的新冠疫苗有效性标准。</p>
<p class="MsoNormal"><strong>其中对<span lang="EN-US">COVID-19</span>重症及以上病例、死亡病例的保护效力均为<span lang="EN-US">100%</span>。</strong></p>

<p class="MsoNormal" style="text-align: center;"><img alt="重症、死亡保护率100% 首个国产重组新冠病毒蛋白疫苗获批" h="400" src="https://img1.mydrivers.com/img/20220302/55b32166-a329-4e4c-806e-69bc086d004b.png" style="text-align: center; border: 1px solid black;" w="600" referrerpolicy="no-referrer"></p>

           
           
<p class="end"><img src="https://icons.mydrivers.com/news/end_article.png" referrerpolicy="no-referrer"></p> 
<div style="overflow: hidden;font-size:14px;">
           <p class="zhuanzai"><strong>如需转载请务必注明出处：快科技</strong></p>  
          <p class="url"><span style="color:#666">责任编辑：宪瑞</span><a href="javascript:;" class="jiucuo" id="leftjiucuo">文章纠错</a></p>
        </div>
        <div class="page_article" id="bnext">
 
</div>
<p class="bqian">话题标签：<a href="https://news.mydrivers.com/tag/yimiao.htm">疫苗</a><a href="https://news.mydrivers.com/tag/xinguanbingdu.htm">新冠病毒</a><a href="https://news.mydrivers.com/tag/xinguanyimiao.htm">新冠疫苗</a>  </p>
        
</div>
            